Initiate cGMP operations at the North Carolina manufacturing facility
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 28 Feb 2023
- Due
- 31 Dec 2023
- Delivered
- by 31 Dec 2023
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Initiate current good manufacturing practice compliant operations at Beam’s internal North Carolina manufacturing facility in late 2023”
What we found
Evidence strength A What the grades mean
Multiple SEC filings confirm that the company successfully initiated cGMP operations at its North Carolina manufacturing facility in late 2023.
-
A Beam Therapeutics Inc. 10-K filed 2024-02-27
“The facility, which initiated cGMP operations in late 2023, is designed to support manufacturing” ✓ confirmed on the page
Market reaction: the shares moved +9.9% against the S&P 500 over the three sessions around the disclosure (26 Feb 2024 to 29 Feb 2024). What this measures
Checked 2 Oct 2026.
Commitment lineage
Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.
- 2 versions
-
Version 1 · original · stated 28 Feb 2023
Deadline 31 Dec 2023 (“in late 2023”)
-
Version 2 · stated 10 May 2023
Deadline 31 Dec 2023 (“late 2023”) · wording expected
“Beam expects to initiate current good manufacturing practice compliant operations at its North Carolina manufacturing facility in late 2023.”
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Production start
- Indicative materiality
- High rules
- Action
- Initiate
- Deliverable
- cGMP operations at North Carolina facility
- Where
- North Carolina
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Beam Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-BEAM-003234 · Corrections policy